Literature DB >> 1139258

Prognostic significance of acute systolic hypertension after myocardial infarction.

K M Fox, I W Tomlinson, R W Portal, C P Aber.   

Abstract

The clinical behaviour and mean peak serum aspartate aminotransferase (SGOT) values of 106 patients admitted to a coronary care unit with acute myocardial infarction who displayed acute systolic hypertension were studied. Another 106 normotensive patients with acute myocardial infarction acted as controls. Neither group had established hypertension. The mortality rate, incidence of cardiac failure, major arrhythmias, and mean peak SGOT were significantly greater in the hypertensive group, within which the duration of hypertension was correlated with mean peak SGOT levels--through there was no definite relation between the height of systolic or diastolic pressure and SGOT. Transient systolic hypertension after acute myocardial infarction was therefore associated with a relatively poor prognosis, but our observations suggest that patients with a systolic blood pressure of at least 170 mm Hg might benefit from early hypotensive treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139258      PMCID: PMC1673992          DOI: 10.1136/bmj.3.5976.128

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  17 in total

1.  THE RECOGNITION OF STRICTLY POSTERIOR MYOCARDIAL INFARCTION BY CONVENTIONAL SCALAR ELECTROCARDIOGRAPHY.

Authors:  J K PERLOFF
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

2.  Plasma catechol amine concentrations in myocardial infarction and angina pectoris.

Authors:  P C GAZES; J A RICHARDSON; E F WOODS
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

3.  Evidence for increased serum glutamic oxalacetic transaminase (SGO-T) activity following graded myocardial infarcts in dogs.

Authors:  I NYDICK; F WROBLEWSKI; J S LADUE
Journal:  Circulation       Date:  1955-08       Impact factor: 29.690

4.  Transaminase in experimental myocardial infarction.

Authors:  J LEMLEY-STONE; J M MERRILL; J T GRACE; G R MENEELY
Journal:  Am J Physiol       Date:  1955-12

5.  A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION.

Authors:  A A Peel; T Semple; I Wang; W M Lancaster; J L Dall
Journal:  Br Heart J       Date:  1962-11

6.  Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique.

Authors:  D C Siggers; C Salter; D C Fluck
Journal:  Br Heart J       Date:  1971-11

7.  Discrepancies between electrocardiographic and enzyme evidence of myocardial infarction.

Authors:  P Marrott; M P Chopra; R W Portal; C P Aber
Journal:  Br Heart J       Date:  1973-12

8.  Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction.

Authors:  D E Jewitt; D Reid; M Thomas; C J Mercer; C Valori; J P Shillingford
Journal:  Lancet       Date:  1969-03-29       Impact factor: 79.321

9.  Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion.

Authors:  J W Hirshfeld; J S Borer; R E Goldstein; M J Barrett; S E Epstein
Journal:  Circulation       Date:  1974-02       Impact factor: 29.690

10.  Modification of myocardial infarction size after coronary occlusion.

Authors:  P R Maroko; E Braunwald
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

View more
  2 in total

1.  Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.

Authors:  M Renard; A Rivière; P Jacobs; R Bernard
Journal:  Br Heart J       Date:  1983-06

2.  Labetalol infusion in acute myocardial infarction with systemic hypertension.

Authors:  P G Marx; D S Reid
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.